Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

HIMS & HERS Aktie

 >HIMS & HERS Aktienkurs 
23.5 EUR    -0.6%    (TradegateBSX)
Ask: 23.84 EUR / 500 Stück
Bid: 23.62 EUR / 500 Stück
Tagesumsatz: 11394 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
HIMS & HERS Aktie über LYNX handeln
>HIMS & HERS Performance
1 Woche: -1,3%
1 Monat: -11,3%
3 Monate: -5,6%
6 Monate: +1,4%
1 Jahr: -46,6%
laufendes Jahr: -19,1%
>HIMS & HERS Aktie
Name:  HIMS & HERS HEALTH INC.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4330001060 / A2QMYY
Symbol/ Ticker:  82W (Frankfurt) / HIMS (NYSE)
Kürzel:  FRA:82W, ETR:82W, 82W:GR, NYSE:HIMS
Index:  -
Webseite:  https://www.hims.com/
Profil:  Hims & Hers Health, Inc. Class A Common Stock is the equity of Hims & Hers Health, a consumer-focused digital health and telehealth platform. Hims & Hers connects customers with licensed healthcare professionals through its websites and mobile app, o..
>Volltext..
Marktkapitalisierung:  5533.79 Mio. EUR
Unternehmenswert:  6151.79 Mio. EUR
Umsatz:  2222.77 Mio. EUR
EBITDA:  74.54 Mio. EUR
Nettogewinn:  -122.45 Mio. EUR
Gewinn je Aktie:  -0.53 EUR
Schulden:  1333.12 Mio. EUR
Liquide Mittel:  525.76 Mio. EUR
Operativer Cashflow:  229.76 Mio. EUR
Bargeldquote:  0.57
Umsatzwachstum:  32.07%
Gewinnwachstum:  -175.67%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.112.606 Euro.
Suchwörter:  HIMS & HERS, HIMS AND HERS, HIMS HERS
Letzte Datenerhebung:  13.09.26
>HIMS & HERS Kennzahlen
Aktien/ Unternehmen:
Aktien: 224.94 Mio. St.
Frei handelbar: 94.17%
Rückkaufquote: 1.01%
Mitarbeiter: 2442
Umsatz/Mitarb.: 0.83 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 18.59%
Bewertung:
KGV: -
KGV lG: -
KUV: 2.46
KBV: 19.19
PEG-Ratio: -
EV/EBITDA: 82.53
Rentabilität:
Bruttomarge: 54.19%
Gewinnmarge: -5.51%
Operative Marge: -0.03%
Managementeffizenz:
Gesamtkaprendite: -5.16%
Eigenkaprendite: -32.03%
>HIMS & HERS Peer Group
 
13.09.26 - 10:48
I′m Calling It: Hims & Hers Health Will Soar 56% by the End of 2026 (Fool)
 
Hims & Hers Health is still growing rapidly, but whether that growth can translate into better economics could determine how much further the stock can climb....
12.09.26 - 18:36
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, Sept. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026......
12.09.26 - 02:30
Hims & Hers Health, Inc. (HIMS) Securities Fraud Class Action Lawsuit Filed; November 2, 2026, Lead Plaintiff Deadline (PR Newswire)
 
Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who: Hims & Hers Health, Inc. (NYSE: HIMS) What: Securities fraud class action lawsuit filed Class Period: August 4, 2025 through July 29, 2026 Deadline to Seek Lead Plaintiff Status:......
11.09.26 - 15:27
Hims & Hers Health resumed at JP Morgan at neutral on GLP-1 compounding headwinds (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.09.26 - 15:01
JPMorgan zu Hims & Hers: Neutrales Votum wegen Risiken bei GLP-1-Umstellung (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
11.09.26 - 14:48
JPMorgan cautious on Hims & Hers on GLP-1 transition risk (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
10.09.26 - 19:15
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS (PR Newswire)
 
SAN FRANCISCO, Sept. 10, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......
09.09.26 - 23:24
Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit Before November 2, 2026 Deadline (PR Newswire)
 
SAN FRANCISCO, Sept. 9, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......
09.09.26 - 19:00
Why Is Hims & Hers Health (HIMS) Down 7.7% Since Last Earnings Report? (Zacks)
 
Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
09.09.26 - 01:00
Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know (Zacks)
 
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $28.17, representing a +1.66% change from its previous close....
08.09.26 - 19:21
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, Sept. 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. IF YOU SUFFERED A LOSS ON YOUR HIMS & HERS HEALTH, INC. INVESTMENTS, CLICK......
07.09.26 - 21:03
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
BENSALEM, Pa., Sept. 7, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS......
07.09.26 - 19:51
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS (PR Newswire)
 
SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......
06.09.26 - 18:03
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm (PR Newswire)
 
NEW YORK, Sept. 6, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of its officers. This lawsuit seeks to recover......
05.09.26 - 16:42
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire)
 
Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who: Hims & Hers Health, Inc. (NYSE: HIMS) What: Securities fraud class action lawsuit filed Class Period: August 4, 2025 through July 29, 2026 Deadline to Seek Lead Plaintiff Status:......
05.09.26 - 04:03
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS (PR Newswire)
 
NEW ORLEANS, Sept. 4, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company")......
04.09.26 - 18:24
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, Sept. 4, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. (HIMS) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH,......
04.09.26 - 03:01
Insiderhandel: Chief Legal Officer verkauft Aktien von Hims Hers Health im Wert von 97965 USD (Insiderkauf)
 
Boughton, Soleil - Vorstand - Tag der Transaktion: 2026-09-02...
03.09.26 - 21:15
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS (PR Newswire)
 
SAN FRANCISCO, Sept. 3, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business......
03.09.26 - 16:18
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS (PR Newswire)
 
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Hafen ist ein reizvoller Aufenthalt für eine im Lebenskampf erschöpfte Seele. - Charles Baudelaire
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!